Skip to main content

and
  1. Article

    Open Access

    The clinical and translational research activities at the INT – IRCCS “Fondazione Pascale” cancer center (Naples, Italy) during the COVID-19 pandemic

    COVID-19 pandemic following the outbreak in China and Western Europe, where it finally lost the momentum, is now devastating North and South America. It has not been identified the reason and the molecular mec...

    Franco M. Buonaguro, Gerardo Botti, Paolo Antonio Ascierto in Infectious Agents and Cancer (2020)

  2. No Access

    Article

    Dabrafenib, trametinib and pembrolizumab or placebo in BRAF-mutant melanoma

    Blocking programmed death 1 (PD-1) may enhance the durability of anti-tumor responses that are induced by the combined inhibition of BRAF and MEK1. Here we performed a randomized phase 2 trial ( ...

    Paolo Antonio Ascierto, Pier Francesco Ferrucci, Rosalie Fisher in Nature Medicine (2019)